Skip to main content
SpringerLink
Log in

Neuroprotective and neurorestorative strategies for neuronal injury

  • Published:
Neurotoxicity Research Aims and scope Submit manuscript

Abstract

Mechanisms of neuronal cell death in apoptosis and necrosis are examined. Neurotoxic processes underlying cellular destruction may involve N-methyl-D-aspartate (NMDA) receptor activation and/or activation of neuronal nitric oxide synthase but the depletion of energy and generation of free radicals appears to be critical. In Alzheimer’s disease the damaging effects of peroxynitrite and exposure to β-amyloid peptide is evident. Mitochondrial dysfunction is involved in several neurodegenerative diseases including Parkinson’s disease, amyotrophic lateral sclerosis, Huntington’s disease as well as Alzheimer’s disease and in these disorders the innovations offered by techniques ranging from transgenic mouse models of the disorder to cell culture preparations are remarkable. Agents of neuroprotection and neurorestoration possess either characteristics specific to particular disorders or have a general applicability or both. The vast array of agents available are for the most part the objectives of laboratory examinations but an increasing selection of compounds are reaching the clinical necessities thereby influencing current strategic notions to modify tactical contingencies. Among the agents listed are included: inhibitors of the enzyme poly-ADP-ribose polymerase, inhibition of apoptotic cell death, agents acting on mitochondrial permeability transition, excitatory amino acid antagonists, applications of neurotrophins, immunophilins, agents influencing heme oxygenase-1 expression and iron sequestration in aging astroglia, improvements in mitochondrial energy production or buffering, and finally dopaminemimetics with differential affinities for dopamine receptors.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Acuña-Castroveijo, D., Coto-Montes, A., Monti, M.G., Ortiz, G.G. and Reiter, R.J. (1997) Melatonin is protective against MPTP-induced striatal and hippocampal lesions.Life Sci. 60, 23–29.

    Google Scholar 

  • Albin, R.L. and Greenamyre, J.T. (1993) Alternative excitotoxic hypotheses.Neurology 42, 733–738.

    Google Scholar 

  • Alexi, T., Venero, J.L. and Hefti, F. (1997) Protective effects of neurotrophin-4/5 and transforming growth factor-alpha on striatal neuronal phenotypic degeneration after excitotoxic lesioning with quinolinic acid.Neuroscience 78, 73–86.

    Article  PubMed  CAS  Google Scholar 

  • Antolin, I., Rodriguez, C, Sainz, R.M., Mayo, J.C., Uria, H., Kotler, M.L., Rodriguez-Colunga, M.J., Tolivia, D. and Menendez-Pelaez, A. (1996) Neurohormone melatonin prevents cell damage: effect on gene expression for antioxidant enzymes.FASEB J. 10, 882–890.

    PubMed  CAS  Google Scholar 

  • Applegate, L.A., Luscher, P. and Tyrrell, R.M. (1991) Induction of heme oxygenase: a general response to oxidant stress in cultured mammalian cells.Cancer Res. 51, 974–978.

    PubMed  CAS  Google Scholar 

  • Archer, T. and Fredriksson, A. (2000) Restoration and putative protection of MPTP-induced functional deficits.Neurotoxicity Res. 2, 251–292 (in press).

    Article  CAS  Google Scholar 

  • Aubin, N., Curet, O., Deffois, A. and Carter, C. (1998) Aspirin and salicylate protect against MPTP-induced dopamine depletion in mice.J. Neumchem. 71, 1635–1642.

    Article  CAS  Google Scholar 

  • Beal, M.F. (1998) Mitochondrial dysfunction in neurodegenerative diseases.Biochim. Biophys. Acta 1402, 211–223.

    Google Scholar 

  • Beal, M.F. (1999) Coenzyme Q10 administration and its potential for treatment of neurodegenerative diseases.Biofactors 9, 261–266.

    Article  PubMed  CAS  Google Scholar 

  • Beal, M.F., Kowall, N.W., Ellison, D.W., Mazurek, M.F., Swartz, K.J. and Martin, J.B. (1986) Replication of the neurochemical characteristics of Huntington’s disease by quinolinic acid.Nature 321, 168–171.

    Article  PubMed  CAS  Google Scholar 

  • Beal, M.F., Henshaw, D.R., Jenkins, B.G., Rosen, B.R. and Schulz, J.B. (1994) Coenzyme Q10 and nicotinamide block striatal lesions produced by the mitochondrial toxin malonate.Ann. Neurol. 36, 882–888.

    Article  PubMed  CAS  Google Scholar 

  • Beal, M.F., Ferrante, R.J., Browne, R.T., Matthews, R.T., Kowall, N.W. and Brown Jr., R.H. (1997) Increased 3-nitrotyrosine in both sporadic and familial amyotrophic lateral sclerosis.Ann. Neurol. 42, 644–654.

    Article  PubMed  CAS  Google Scholar 

  • Behl, C. and Holsboer, F. (1999) The female sex hormone oestrogen as a neuroprotectant.TIPS 20, 441–444.

    PubMed  CAS  Google Scholar 

  • Beninger, R.J., Dringenberg, H.C., Boegman, R.J. and Jhamandas, K. (2000) Cognitive effects of neurotoxic lesions of the nucleus basalis magnocellularis in rats: differential roles for corticopetal versus amygdalopetal projections.Neurotoxicity Res. 2, abc-xyz (in press).

    Google Scholar 

  • Ben-Shachar, D., Eshel, G., Finberg, J.P.M. and Youdim, M.B.H. (1991) The iron chelator deferoxamine (desferal) retards 6-hydroxydopamine-induced degeneration of nigro-striatal neurons.J. Neumchem. 56, 1441–1444.

    Article  CAS  Google Scholar 

  • Bergquist, J., Tarkowski, A., Ewing, A. and Ekman, R. (1998) Catecholaminergic suppression of immunocompetent cells.Immunol. Today 19, 562–567.

    Article  PubMed  CAS  Google Scholar 

  • Binienda, Z., Johnson, J.R., Tyler-Hashemi, A.A., Roundtree, R.L., Sapienza, P.P., Syed, F. Ali and Kim, C.S. (1999) Protective effect of L-carnitine in the neurotoxicity induced by the mitochondrial inhibitor 3-nitropropionic acid (3-NPA).Ann. NY Acad. Sci. 890, 173–178.

    Article  PubMed  CAS  Google Scholar 

  • Boegman, R.J., el-Defrawy, S.R., Jhamandas, K., Beninger, R.J. and Ludwin, S.K. (1985) Quinolinic acid neurotoxicity in the nucleus basalis antagonised by kynurenic acid.Neurobiol. Aging 6, 331–336.

    Article  PubMed  CAS  Google Scholar 

  • Boegman, R.J., Cockhill, J., Jhamandas, K. and Beninger, R.J. (1992) Differential sensitivity of basal forebrain cholinergic neurons to excitotoxins.Neuroscience 51, 129–136.

    Article  PubMed  CAS  Google Scholar 

  • Borden, K.L. (1998) Structure/function in neuroprotection and apoptosis.Ann. Neurol. 44(Suppl. 1), 65–71.

    Google Scholar 

  • Bridelli, M.G., Tampellini, D. and Zecca, L. (1999) The structure of neuromelanin and its iron binding site studied by infrared spectroscopy.FEES Lett. 457, 18–22.

    Article  CAS  Google Scholar 

  • Cagnoli, CM., Atabay, C, Kharlamov, E. and Manev, H. (1995) Melatonin protects neurons from singlet oxygen-induced apoptosis.J. Pineal Res. 18, 222–226.

    Article  PubMed  CAS  Google Scholar 

  • Cardoso, S.M., Pereira, C. and Oliveira, R. (1999) Mitochondrial function is differentially affected upon oxidative stress.Free Radic. Biol. Med. 26, 3–13.

    Article  PubMed  CAS  Google Scholar 

  • Cassarino, D.S., Fall, C.P., Smith, T.S. and Bennett, J.P. (1998) Pramipexole reduces reactive oxygen species productionin vivo andin vitro and inhibits the mitochondrial per-meability transition produced by the Parkin- sonian neuro-toxin methylpyridinium ion.J. Neumchem. 71, 295–301.

    Article  CAS  Google Scholar 

  • Chabrier, P.E., Demerle-Pallardy, C. and Auguet, M. (1999) Nitric oxide synthases: targets for therapeutic strategies in neurological diseases.Cell Mol. Life Sci. 55, 1029–1035.

    Article  PubMed  CAS  Google Scholar 

  • Charriant-Marlangue, C, Aggoun-Zouaoui, D., Represa, A. and Ben-Ari, Y. (1996) Apoptotic features of selective neuronal death in ischemia, epilepsy and gp 120 toxicity.Trend. Neumsci. 19, 109–114.

    Article  Google Scholar 

  • Chiueh, C.C., Lee, S.Y., Andoh, T., Lai, A.R., Lai, E. and Krishna, G. (2000) Neuroprotective strategies in Parkinson’s disease: protection against progressive nigral damage induced by free radicals.Neurotoxicity Res. 2, 293–310 (in press).

    Article  CAS  Google Scholar 

  • Cho, S., Joh, T.H., Baik, H.H., Dibinis, C. and Volpe, B.T. (1997) Melatonin administration protects CAI hippocampal neurons after transient forebrain ischemia in rats.Brain Res. 755, 335–338.

    Article  PubMed  CAS  Google Scholar 

  • Cohen, G. (1987) Monoamine oxidase, hydrogen peroxide, and Parkinson’s disease.Adv. Neurol. 45, 119–125.

    PubMed  CAS  Google Scholar 

  • Connick, J.H., Heywood, G.C., Sills, G.J., Thompson, G.G., Brodie, M.J. and Stone, T.W. (1992) Nicotinylalanine increases cerebral kynurenic acid content and has anticonvulsive activity.General Pharmacol. 23, 235–239.

    CAS  Google Scholar 

  • Connor, B. and Dragunow, M. (1998) The role of neural growth factors in degenerative disorders of the human brain.Brain Res. Rev. 27, 1–39.

    Article  PubMed  CAS  Google Scholar 

  • Coyle, J.T. and Puttfarcken, P. (1993) Oxidative stress, glutamate and neurodegenerative disorders.Science 262, 689–695.

    Article  PubMed  CAS  Google Scholar 

  • Cummings, J.L. and Cotman, C.W. (1995) Image analysis of β-amyIoid load in Alzheimer’s disease and relation to dementia severity.Lancet 346, 1524–1528.

    Article  PubMed  CAS  Google Scholar 

  • Cummings, J.L. and Kaufer, D. (1996) Neuropsychiatric aspects of Alzheimer’s disease: the cholinergic hypothesis revisited.Neurology 47, 876–883.

    PubMed  CAS  Google Scholar 

  • Danysz, W., Parsons, C.R., Möbius, H.-J., Stöffler and Quack, G. (2000) Neuroprotective and symptomatological action of memantine relevant for Alzheimer’s disease — a unified hypothesis on the mechanism of action.Neurotoxicity Res. 2, 85–97 (in press).

    Article  CAS  Google Scholar 

  • Dawson, V.L., Dawson, T.M., Bartley, T.A., Uhl, G.R. and Snyder, S.H. (1993) Mechanisms of nitric oxide-mediated neurotoxicity in primary brain cultures.J. Neurosci. 13, 2651–2661.

    PubMed  CAS  Google Scholar 

  • Delatycki, M.B., Paris, D.B., Gardner, R.J., Nicholson, G.A., Nassif, N., Storey, E., MacMillan, J.C., Collins, V, Williamson, R. and Forrest, S.M. (1999) Clinical and genetic study of Friedreich ataxia in an Australian population.Am. J. Med. Genet. 87, 168–174.

    Article  PubMed  CAS  Google Scholar 

  • Dexter, D.T., Holley, A.E., Flitter, W.D., Slater, T.F., Wells, F.R., Daniel, S.E., Lees, A.J., Jenner, P. and Marsden, CD. (1994) Increased levels of lipid hydroperoxides in the parkinsonian substantia nigra: an HPLC and ESR study.Mov. Disord. 9, 92–97.

    Article  PubMed  CAS  Google Scholar 

  • De Yebenes, J.G. and Mena, M.A. (2000) Neurotrophic factors in neurodegenerative disorders: model of Parkinson’s disease.Neurotoxicity Res. 2, 115–137 (in press).

    Article  Google Scholar 

  • Docherty, J.C., Kuzio, B., Silvester, J.A., Bowes, J. and Thiemermann, C. (1999) An inhibitor of poly (ADP-ribose) synthetase activity reduces contractile dysfunction and preserves high energy phosphate levels during reperfusion of the ischaemic rat heart.Br. J. Pharmacol. 127, 1518–1524.

    Article  PubMed  CAS  Google Scholar 

  • Doré, S., Takahashi, M., Ferris, CD., Hester, L.D., Guastella, D. and Snyder, S.H. (1999) Bilirubin, formed by activation of heme oxygenase-2, protects neurons against oxidative stress injury.Proc. Natl. Acad. Sci. USA 96, 2445–2450.

    Article  PubMed  Google Scholar 

  • Double, K.L., Maywald, M., Schmittel, M., Riederer, P. and Gerlach, M. (1998)In vitro studies of ferritin iron release and neurotoxicity.J. Neurochem. 70, 2492–2499.

    Article  PubMed  CAS  Google Scholar 

  • Ellison, G. (1995) The N-methyl-D-aspartate antagonists phencyclidine, ketamine and dizocilpine as both behavioral and anatomical models of the dementias.Brain Res. Bull 20, 250–267.

    CAS  Google Scholar 

  • Escames, G., Guerrero, J.M., Reiter, R.J., Garcia, J.J., Munoz-Hoyos, A., Ortiz, G.G. and Oh, C.S. (1997) Melatonin and vitamin E limit nitric oxide-induced lipid peroxidation in rat brain homogenates.Neurosci. Lett. 230, 147–150.

    Article  PubMed  CAS  Google Scholar 

  • Ferrante, R.J., Shinobu, J.B., Schulz, J.B., Matthews, R.T., Thomas, C.E., Kowall, N.W., Gurney, N.E. and Beal, M.F. (1997) Increased 3-nitrotyrosine and oxidative damage in mice with a human copper/zinc Superoxide dismutase mutation.Ann. Neurol. 42, 326–334.

    Article  PubMed  CAS  Google Scholar 

  • Floreani, M., Skaper, S.D., Facci, L., Lipartiti, M. and Giusti, P. (1997) Melatonin maintains glutathione homeostasis in kainic acid-exposed rat brain tissues.FASEB J. 11, 1309–1315.

    PubMed  CAS  Google Scholar 

  • Fredriksson, A., Plaznik, A., Sundstrom, E. and Archer, T. (1994) Effects of D1 and D2 agonists on spontaneous motor activity in MPTP treated mice.Pharmacol. Toxicol. 75, 36–41.

    Article  PubMed  CAS  Google Scholar 

  • Friedlich, A. and Beal, F. (2000) Prospects for redox-based therapy in neurodegenerative diseases.Neurotoxicity Res. 2, 229–237 (in press).

    Article  CAS  Google Scholar 

  • Gassen, M., Glinka, Y., Pinchasi, B. and Youdim, M.B.H. (1996) Apomorphine is a highly potent free radical scavenger in rat brain mitochondrial fraction.Eur. J. Pharmacol. 308, 219–225.

    Article  PubMed  CAS  Google Scholar 

  • Gassen, M., Gross, A. and Youdim, M.B.H. (1998) Apomorphine enantiomers protect cultured pheochromo-cytoma (PC12) cells from oxidative stress induced by H2O2 and 6-hydroxydopamine.Mov. Disord. 13, 242–248.

    Article  PubMed  CAS  Google Scholar 

  • Garthwaite, G. and Garthwaite, J. (1987) Receptor-linked ionic channels mediate N-methyl-D-aspartate neurotoxicity in rat cerebellar slices.Neurosci. Lett. 83, 241–246.

    Article  PubMed  CAS  Google Scholar 

  • Garthwaite, G. and Garthwaite, J. (1989) Neurotoxicity of excitatory amino acid receptor agonists in young rat hippocampal slices.J. Neurosci. Meth. 29, 33–42.

    Article  CAS  Google Scholar 

  • Gash, D.M., Zhang, Z. and Gerhardt, G. (1998) Neuroprotective and neurorestorative properties of GDNF.Ann. Neurol. 44, 121–125.

    Google Scholar 

  • Gelman, B.B. (1995) Iron in CNS disease.J. Neuropathol. Exp. Neurol. 54, 477–486.

    Article  PubMed  CAS  Google Scholar 

  • Gerlach, M. and Riederer, P. (1996) Animal models of Parkinson’s disease: an empirical comparison with the phenomenology of the disease in man.J. Neural Transm. 103, 987–1041.

    Article  PubMed  CAS  Google Scholar 

  • Gerlach, M. and Riederer, P. (1999) Time sequences of dopaminergic cell death in Parkinson’s disease. Indications for neuroprotective studies.Adv. Neurol. 80, 219–225.

    PubMed  CAS  Google Scholar 

  • Gerlach, M., Riederer, P. and Youdim, M.B.H. (1992) The molecular pharmacology of L-Deprenyl.Eur. J. Pharmacol. (Mol. Pharmacol. Sect.) 226, 97–108.

    CAS  Google Scholar 

  • Gerlach, M., Ben-Shahar, D., Riederer, P. and Youdim, M.B.H. (1994) Altered brain metabolism of iron as a cause of neurodegenerative diseases?J. Neurochem. 63, 793–807.

    Article  PubMed  CAS  Google Scholar 

  • Gerlach, M., Double, K.L., Youdim, M.B.H. and Riederer, P. (2000) Strategies for the protection of dopaminergic neurons against neurotoxicity.Neurotoxicity Res. 2, 99–114 (in press).

    Article  CAS  Google Scholar 

  • Giusti, P., Franceschini, D., Pétrone, M., Manev, H. and Floreani, M. (1996)In vivo andin vitro protection against kainate-induced excitotoxicity by melatonin.J. Pineal Res. 20, 226–231.

    Article  PubMed  CAS  Google Scholar 

  • Gong, Y.H., Parsadanian, A.S., Andreeva, A., Snider, W.D. and Elliott, J.L. (2000) Restricted expression of G86R Cu/Zn Superoxide dismutase in astrocytes results in astrocytosis but does not cause motoneuron degeneration.J. Neurochem. 20, 660–665.

    CAS  Google Scholar 

  • Good, P.F., Werner, P., Hsu, A., Olanow, C.W. and Perl, D.P. (1996) Evidence of neuronal oxidative damage in Alzheimer’s disease.Amer. J. Pathol. 149, 21–28.

    CAS  Google Scholar 

  • Grandas, F. (2000) The putative neuroprotective role of dopamine agonists in Parkinson’s disease.Neurotoxicity Res. 2, 205–213 (in press).

    Article  CAS  Google Scholar 

  • Grunblatt, E., Mandel, S., Berkuzki, T. and Youdim, M.B.H. (1999) Apomorphine protects against MPTP-induced neurotoxicity in mice.Mov. Disord. 14, 612–618.

    Article  PubMed  CAS  Google Scholar 

  • Hansson, O., Petersen, A., Leist, M., Nicotera, P., Castilho, R.F. and Brundin, P. (1999) Transgenic mice expressing a Huntington’s disease mutation are resistant to quinolinic acid-induced striatal excitotoxicity.Proc. Natl. Acad. Sci. 96, 8727–8732.

    Article  PubMed  CAS  Google Scholar 

  • Hantraye, P., Brouiller, E., Ferrante, R., Palfi, S., Dolan, R., Matthews, R.T. and Beal, M.F. (1996) Inhibition of neuronal nitric oxide synthase prevents MPTP-induced parkinsonism in baboons.Nat. Med. 2, 1017–1021.

    Article  PubMed  CAS  Google Scholar 

  • Harris, C.A., Miranda, A.F., Tanguay, J.J., Boegman, R.J., Beninger, R.J. and Jhamandas, K. (1998) Modulation of striatal quinolinate neurotoxicity by elevation of endogenous brain kynurenic acid.Brit. J. Pharmacol. 124, 391–399.

    Article  CAS  Google Scholar 

  • Hayes, M.W., Ouvrier, R.A., Evans, W., Somerville, E. and Morris, J.G. (1998) X-Linked dystonia-deafness syndrome.Mov. Disord. 13, 303–308.

    Article  PubMed  CAS  Google Scholar 

  • Hefti, E, Hartikka, J. and Knusel, B. (1989) Function of neurotrophic factors in the adult and aging brain and their possible uses in the treatment of neurodegenerative disease.Neurobiol. Aging 10, 515–533.

    Article  PubMed  CAS  Google Scholar 

  • Hensley, K., Maidt, M.D., Yu, Z., Sang, H., Markesbury, W.R. and Floyd, R.A. (1998) Electrochemical analysis of protein nitrotyrosine and dityrosine in the Alzheimer brain indicates region-specific accumulation.J. Neurosci. 18, 8126–8132.

    PubMed  CAS  Google Scholar 

  • Heyes, M.P., Saito, K., Major, E.O., Milstein, S., Markey, S.P. and Vickers, J.H. (1993) A mechanism of quinolinic acid formation by brain in inflammatory neurological disease. Attenuation of synthesis from L-tryptophan by 6-chloro- tryptophan and 4-chloro-3-hydroxyanthranilate.Brain 116, 1425–1450.

    PubMed  Google Scholar 

  • Hodgson, J.G., Agopyan, N., Gutekunst, CA., Leavitt, B.R., LePaine, F., Singaraja, R., Smith, D.J., Bissada, N., McCutcheon, K., Nasir, J., Jamot, L., Li, X.J., Stevens, M.E., Rosemond, E., Roder, J.C., Phillips, A.G., Rubin, E.M., Hersch, S.M. and Hayden, M.R. (1999) A YAC mouse model for Huntington’s disease with full-length mutant huntingtin, cytoplasmic toxicity, and selective striatal neurodegeneration.Neuron 23, 181–192.

    Article  PubMed  CAS  Google Scholar 

  • Jellinger, K., Keizl, E., Rumpelmair, G., Riederer, P. and Youdim, M.B.H. (1992) Iron melanin complex in substantia nigra of Parkinsonian brains: an X-ray microanalysis.J. Neurochem. 59, 1168–1171.

    Article  PubMed  CAS  Google Scholar 

  • Jenkins, B.G., Rosas, H.D., Chen, Y.C., Makabe, T., Myers, R., MacDonald, M., Rosen, B.R., Beal, M.F. and Koroshetz, W.J. (1998) 1H NMR spectroscopy studies of Huntington’s disease: correlations with CAG repeat numbers.Neurology 50, 1357–1365.

    PubMed  CAS  Google Scholar 

  • Jhamandas, K.H., Boegman, R.J., Beninger, R.J., Miranda, A.F. and Lipic, K.A. (2000) Excitotoxicity of quinolinic acid: modulation by endogenous antagonists.Neurotoxicity Res. 2, 139–155 (in press).

    Article  CAS  Google Scholar 

  • Johnson, J.W. and Ascher, P. (1987) Glysine potentiates the NMDA response in cultured mouse brain neurons.Nature 325, 529–531.

    Article  PubMed  CAS  Google Scholar 

  • Kaemmerer, W.F. and Low, W.C. (1999) Cerebellar allografts survive and transiently alleviate ataxia in a transgenic model of spinocerebellar ataxia type-1.Exp. Neurol. 158, 301–311.

    Article  PubMed  CAS  Google Scholar 

  • Kalda, A., Kaasik, A., Vassiljev, V., Pokk, P. and Zharkovsky, A. (2000) Neuroprotective action of group I metabotropic glutamate receptor agonists against oxygen-glucose- deprivation-induced neuronal death.Brain Res. 853, 370–373.

    Article  PubMed  CAS  Google Scholar 

  • Kalra, S., Arnold, D.L. and Cashman, N.R. (1999) Biological markers in the diagnosis and treatment.J. Neurol. Sci. 165(Suppl. 1), S27-S32.

    Article  PubMed  CAS  Google Scholar 

  • Kard, P., LeBlanc, G., Hackett, C., Beninger, R.J., Boegman, R.J. and Jhamandas, K. (1998) Nitroglycerin protects striatonigral dopaminergic neurons from NMDA-induced excitotoxic damage.Naunyn-Schmiedeberg’s Arch. Pharmacol. 358(Suppl. 1), R142-R143.

    Google Scholar 

  • Kienzl, E., Jellinger, K., Stachelberger, H. and Linert, W. (1999) Iron as catalyst for oxidative stress in the pathogenesis of Parkinson’s disease?Life Sci. 65, 1973–1976.

    Article  PubMed  CAS  Google Scholar 

  • Kinloch, R.A., Treherne, J.M., Furness, L.M. and Hajimohamadreza, I. (1999) The pharmacology of apoptosis.TIPS 20, 35–42.

    PubMed  CAS  Google Scholar 

  • Kitada, T., Asakawa, S., Hattori, N., Matsunine, H., Yamamura, Y., Minoshima, S., Yokochi, M., Mizuno, Y. and Shimizu, N. (1998) Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism.Nature 392, 605–608.

    Article  PubMed  CAS  Google Scholar 

  • Kitamura, Y, Itano, Y, Kubo, T. and Nomura, Y (1994) Suppressive effect of FK-506, a novel immunosuppressant, against MPTP-induced dopamine depletion in the striatum of young C57/BL/6 mice.J. Neuroimmunol. 50, 221–224.

    Article  PubMed  CAS  Google Scholar 

  • Klivenyi, P., Ferrante, R.J., Matthews, R.T, Bogdanov, M.B., Klein, A.M., Andreassen, O.A., Mueller, G., Wermer, M., Kaddurah-Daouk, R. and Beal, M.F. (1999) Neuroprotective effects of creatine in a transgenic animal model of amyotrophic lateral sclerosis.Nat. Med. 5, 347–350.

    Article  PubMed  CAS  Google Scholar 

  • Knopman, D., Schneider, L., Davis, K., Talwalker, S., Smith, F., Hoover, T. and Gracon, S. (1996) Long-term tacrine (Cognex) treatment: effects on nursing home placement and mortality, Tacrine Study Group.Neurology 47, 166–177.

    PubMed  CAS  Google Scholar 

  • Koehler, C.M., Leuenberger, D., Merchant, S., Renold, A., Junne, T. and Schatz, G. (1999) Human deafness dystonia syndrome is a mitochondrial disease.Proc. Natl. Acad. Sci. USA 96, 2141–2146.

    Article  PubMed  CAS  Google Scholar 

  • Kostrzewa, R.M. (2000) Review on apoptosis vs. necrosis of substantia nigrapars compacta in Parkinson’s disease.Neurotoxicity Res. 2, 239–250 (in press).

    Article  CAS  Google Scholar 

  • Kropf, A.J., Bunker, B.A., Eisner, M., Moss, S.C., Zecca, L., Stroppolo, A. and Crippa, P.R. (1998) X-Ray absorption fine- structure spectroscopy studies of Fe sites in natural human neuromelanin and synthetic analogues.Biophys.J. 75, 3135–3142.

    Article  PubMed  CAS  Google Scholar 

  • Kruger, W., Kuhn, W., Muller, T., Woitalla, D., Graeber, M., Kosel, S., Przuntek, H., Epplen, J.T., Schols, L. and Riess, O. (1998) Ala39Pro mutation in the gene encoding α-synuclein in Parkinson’s disease.Nature Genet. 18, 106–108.

    Article  PubMed  CAS  Google Scholar 

  • Kruman, I.I., Pedersen, W.A., Springer, J.E. and Mattson, M.P. (1999) ALS-linked Cu/Zn-SOD mutation increases vulnerability of motor neurons to excitotoxicity by a mechanism involving increased oxidative stress and perturbed calcium homeostasis.Exp. Neurol. 160, 28–29.

    Article  PubMed  CAS  Google Scholar 

  • Lapchak, P.A., Gash, D.M., Collins, F., Hilt, D., Miller, P.J. and Araujo, D.M. (1997) Pharmacological activities of glial cell line-derived neurotrophic factor (GDNF): preclinical development and application to the treatment of Parkinson’s disease.Exp. Neurol. 145, 309–321.

    Article  PubMed  CAS  Google Scholar 

  • Lee, W.T., Shen, Y.Z. and Chang, C. (2000) Neuroprotective effect of lamotrigine and MK-801 on rat brain lesions induced by 3-nitropropionic acid: evaluation by magnetic resonance imaging andin vivo proton magnetic resonance spectroscopy.Neuroscience 95, 89–95.

    Article  PubMed  CAS  Google Scholar 

  • Levi-Montalcini, R. (1987) The nerve growth factor 35 years later.Science 237, 1154–1162.

    Article  PubMed  CAS  Google Scholar 

  • Link, G., Konijn, A.M. and Hersko, C. (1999) Cardioprotective effect of alpha-tocopherol, ascorbate, deferoxamine, and deferiprone: mitochondrial junction in cultured, ironloaded heart cells.J. Lab. Clin. Med. 133, 179–188.

    Article  PubMed  CAS  Google Scholar 

  • Lione, L.A., Carter, R.J., Hunt, M.J., Bates, G.P., Morton, A.J. and Dunnett, S.B. (1999) Selective discrimination learning impairments in mice expressing the human Huntington’s disease mutation.J. Neurosci. 19, 10428–10437.

    PubMed  CAS  Google Scholar 

  • Liu, D., Wen, J. and Liu, L. (1999) The roles of free radicals in amyotrophic lateral sclerosis: reactive oxygen species and elevated oxidation of protein, DNA, and membrane phospholipids.FASEB J. 13, 2318–2328.

    PubMed  CAS  Google Scholar 

  • Lopez-Lozano, J.J., Bravo, G., Abascal, J., Brera, B., Pascual, M.L., Martinez, R., de la Torre, C. and Moreno, R. (1996) Clinical experience with cotransplantation of peripheral nerve and adrenal medulla in patients with Parkinson’s disease.Transpl. Int. 9, 5485–5491.

    Article  Google Scholar 

  • Mallet, P.E., Beninger, R.J., Flesher, S.N., Jhamandas, K. and Boegman, R.J. (1995) Nucleus basalis lesions: implication of basoamygdaloid cholinergic pathways in memory.Brain Res. Bull. 36, 51–56.

    Article  PubMed  CAS  Google Scholar 

  • Manahan-Vaughan, D., Herrero, I., Reymann, K.G. and Sanchez-Prieto, J. (1999) Presynaptic group 1 metabotropic glutamate receptors may contribute to the expression of long-term potentiation in the hippocampal CA1 region.Neuroscience 94, 71–82.

    Article  PubMed  CAS  Google Scholar 

  • Matthews, R.T., Ferrante, R.J., Klivenyi, P., Yang, L., Klein, A.M., Mueller, G., Kaddurah-Daouk, R. and Beal, M.F. (1999) Creatine and cyclocreatine attenuate MPTP neurotoxicity.Exp. Neurol. 157, 142–149.

    Article  PubMed  CAS  Google Scholar 

  • Melchiorri, D., Reiter, R.J., Sewerynek, E., Chen, L.D. and Nisticó, G. (1995) Melatonin reduces kainate-induced lipid peroxidation in homogenates of different brain regions.FASEB J. 9, 1205–1210.

    PubMed  CAS  Google Scholar 

  • Melchiorri, D., Reiter, R.J., Sewerynek, E., Hara, M., Chen, L.D. and Nisticó, G. (1996) Paraquat toxicity and oxidative damage: reduction by melatonin.Biochem. Pharmacol. 51, 1095–1099.

    Article  PubMed  CAS  Google Scholar 

  • Meldrum, B.S. and Garthwaite, J. (1990) Excitatory amino acid neurotoxicity and neurodegenerative disease.TIPS 11, 379–387.

    PubMed  CAS  Google Scholar 

  • Miranda, A.F., Sutton, M.A., Beninger, R.J., Jhamandas, K. and Boegman, R.J. (1999) Quinolinic acid lesion of the nigrostriatal pathway: effect on turning behaviour and protection by elevation of endogenous kynurenic acid in Rattus Norvegicus.Neurosci. Lett. 262, 81–84.

    Article  PubMed  CAS  Google Scholar 

  • Nordberg, A. (2000) Neuroprotection in Alzheimer’s disease — new strategies for treatment.Neurotoxicity Res. 2, 157–165 (in press).

    Article  CAS  Google Scholar 

  • Olney, J.W. (1990) Excitotoxic amino acids and neuropsychiatric disorders.Ann. Rev. Pharmacol. Toxicol. 30, 47–71.

    Article  CAS  Google Scholar 

  • Olney, J.W., Labruyere, J., Wang, G., Wozniak, D., Price, M. and Sesma, M. (1991) NMDA antagonist neurotoxicity: mechanisms and prevention.Science 254, 1515–1518.

    Article  PubMed  CAS  Google Scholar 

  • Opacka-Juffry, J., Wilson, A.W. and Blunt, S.B. (1998) Effects of pergolide treatment onin vivo hydroxyl free radical formation during infusion of 6-hydroxydopamine in rat striatum.Brain Res. 810, 27–33.

    Article  PubMed  CAS  Google Scholar 

  • Pappolla, M.A., Sos, M., Omar, R.A., Bick, R.J., Hickson-Bick, D.L.M., Reiter, R.J., Efthimiopoulos, S. and Robakis, N.K. (1997) Melatonin prevents death of neuroblastoma cells exposed to the Alzheimer amyloid peptide.J. Neurosci. 17, 1683–1690.

    PubMed  CAS  Google Scholar 

  • Pike, C.J., Walencewicz, A.J., Glabe, C.G. and Cotman, C.W. (1991)In vitro aging of beta-amyloid protein causes peptide aggregation and neurotoxicity.Brain Res. 563, 311–314.

    Article  PubMed  CAS  Google Scholar 

  • Pike, C.J., Balázs, R. and Cotman, C.W. (1996) Attenuation of β-amyloid neurotoxicityin vitro by potassium-induced depolarization.J. Neurochem. 67, 1774–1777.

    Article  PubMed  CAS  Google Scholar 

  • Polymeropoulos, M.H., Laavedan, C, Leroy, E., Ide, S., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R.et al. (1997) Mutation in the α-synuclein gene identified in families with Parkinson’s disease.Science 276, 2045–2047.

    Article  PubMed  CAS  Google Scholar 

  • Pozo, D., Reiter, R.J., Calvo, J.R. and Guerrero, J.M. (1994) Physiological concentrations of melatonin inhibit nitric oxide synthase in rat cerebellum.Life Sci. 55, 455–460.

    Article  Google Scholar 

  • Reddy, PH., Williams, M. and Tagle, D.A. (1999) Recent advances in understanding the pathogenesis of Huntington’s disease.Trend. Neurosci. 22, 248–255.

    Article  PubMed  CAS  Google Scholar 

  • Reinholz, M.M., Merkle, CM. and Poduslo, J.F. (1999) Therapeutic benefits of putrescine-modified catalase in a transgenic mouse model of familial amyotrophic lateral sclerosis.Exp. Neurol. 159, 204–216.

    Article  PubMed  CAS  Google Scholar 

  • Reiter, R.J., Tang, L., Garcia, J.J. and Muñoz-Hoyos, A. (1997) Pharmacological actions of melatonin in oxygen radical pathophysiology.Life Sci. 60, 2255–2271.

    Article  PubMed  CAS  Google Scholar 

  • Romer, W., Oettel, M., Droescher, P. and Schwarz, S. (1997) Novel “scavestrogens” and their radical scavenging effects, iron-chelating, and total antioxidative activities: Δ8,9-dehydro derivatives of 17α-estradiol and 17β-estradiol.Steroids 62, 304–310.

    Article  PubMed  CAS  Google Scholar 

  • Rupniak, H.T.R., Joy, K.A., Atkin, C, Brown, G., Barnes, J.C, Doctrow, S.R., Malfroy, B., Wong, T., Anderson, I.K., Malloy, C.R., Mills, G.I. and Soden, P. (2000) Oxidative neuropathology and putative chemical entities for Alzheimer Disease: Neuroprotective effects of salen-manganese catalytic anti-oxidants.Neurotoxicity Res. 2, 167–178 (in press).

    Article  CAS  Google Scholar 

  • Rustin, P., von Kleist-Retzow, J.C, Chantrel-Groussard, K., Sidi, D., Munnich, A. and Rotig, A. (1999) Effect of idebenone on cardiomyopathy in Friedreich’s ataxia: a preliminary study.Lancet 354, 477–479.

    Article  PubMed  CAS  Google Scholar 

  • Salvati, P.et al. (1999) Brain concentrations of kynurenic acid a systemic neuroprotective dose in the gerbil model of global ischemia.Prog. Neuropsychopharmacol. Biol. Psychiat. 23, 741–752.

    Article  CAS  Google Scholar 

  • Sawada, H., Ibi, M., Kihara, T., Urushitani, M., Akaike, A., Kimura, J. and Shimohama, S. (1998) Dopamine D2-type agonists protect mesencephalic neurons from glutamate neurotoxicity: mechanisms of neuroprotective treatment against oxidative stress.Ann. Neurol. 44, 110–119.

    Article  PubMed  CAS  Google Scholar 

  • Schapira, A.H. (1999) Mitochondrial involvement in Parkinson’s disease, Huntington’s disease, hereditary spastic paraplegia and Friedreich’s ataxia (see comments).Biochim. Biophys. Acta 1410, 159–170.

    Article  PubMed  CAS  Google Scholar 

  • Schapira, A.H., Cooper, J.M., Dexter, D., Clark, J.B., Jenner, P. and Marsden, CD. (1990) Mitochondrial complex I deficiency in Parkinson’s disease.J. Neurochem. 54, 823–827.

    Article  PubMed  CAS  Google Scholar 

  • Schipper, H.M. (1996) Astrocytes, brain aging and neurodegeneration.Neurobiol. Aging 17, 467–480.

    Article  PubMed  CAS  Google Scholar 

  • Schipper, H.M. (1999) Glial HO-1 expression, iron deposition and oxidative stress in neurodegeneration diseases.Neuwtoxicity Res. 1, 57–70.

    Article  CAS  Google Scholar 

  • Schipper, H.M., Cissé, S. and Stopa, E.G. (1995) Expression of heme oxygenase-1 in senescent and Alzheimer-diseased brain.Ann. Neurol. 37, 758–768.

    Article  PubMed  CAS  Google Scholar 

  • Schipper, H.M., Liberman, A. and Stopa, E.G. (1998) Neural heme oxygenase-1 expression in Parkinson’s disease.Exp. Neurol. 150, 60–68.

    Article  PubMed  CAS  Google Scholar 

  • Schipper, H.M., Bernier, L., Mehindate, K. and Frankel, D. (1999) Mitochondrial iron sequestration in dopamine-challenged astroglia: role of heme oxygenase-1 and the permeability transition pore.J. Neurochem. 72, 1802–1811.

    Article  PubMed  CAS  Google Scholar 

  • Schulz, J.B., Matthews, R.T., Muqit, M.M., Browne, S.E. and Beal, M.F. (1995) Inhibition of neuronal nitric oxide synthase by 7-nitroindazole protects against MPTP- induced neurotoxicity in mice.J. Neurochem. 64, 936–939.

    Article  PubMed  CAS  Google Scholar 

  • Schulz, J.B., Henshaw, D.R., MacGarvey, U. and Beal, M.F. (1996) Involvement of oxidative stress in 3-nitropropionic acid neurotoxicity.Neurochem. Intl. 29, 167–171.

    Article  CAS  Google Scholar 

  • Schwarcz, R., Whetsell Jr., W.O. and Mangano, R.M. (1983) Quinolinic acid: an endogenous metabolite that produces axon-sparing lesions in rat brain.Science 219, 316–318.

    Article  PubMed  CAS  Google Scholar 

  • Sethy, V.H., Wu, H., Oosteven, J.A. and Hall, E.D. (1997) Neuroprotective effects of the dopamine agonists pramipexole and bromocriptine in 3-acetylpyridine- treated rats.Brain Res. 754, 181–186.

    Article  PubMed  CAS  Google Scholar 

  • Skaper, S.D., Floreani, M., Ceccon, M., Facci, L. and Giusti, P. (1999) Excitotoxicity, oxidative stress, and the neuroprotective potential of melatonin.Ann. NY Acad. Sci. 890, 107–118.

    Article  PubMed  CAS  Google Scholar 

  • Smith, M.A., Harris, R.P.L., Sayre, L.M., Beckman, J.S. and Perry, G. (1997) Widespread peroxynitrite-mediated damage in Alzheimer’s disease.J. Neurosci. 17, 2653–2657.

    PubMed  CAS  Google Scholar 

  • Smythies, J. (1999) The neurotoxicity of glutamate, dopamine, iron and reactive oxygen species: functional interrelationships in health and disease: a review — discussion.Neurotoxicity Res. 1, 27–39.

    Article  CAS  Google Scholar 

  • Spillantini, M.G., Schmidt, M.L., Lee, V.M., Trojanowski, J.Q., Jakes, R. and Goedert, M. (1997) α-Synuclein in Lewy bodies.Nature 388, 839–840.

    Article  PubMed  CAS  Google Scholar 

  • Sonsalla, P.K., Nicklas, W.J. and Heikkila, R.E. (1989) Role of excitatory amino acids in methamphetamine-induced nigrostriatal dopaminergic toxicity.Science 243, 398–400.

    Article  PubMed  CAS  Google Scholar 

  • Steiner, J.P., Hamilton, G.S., Ross, D.T., Valentine, H.L., Guo, H.Z., Connolly, M.A., Liang, S., Ramsey, C, Li, J.H.J., Huang, W., Howorth, P., Soni, R., Fuller, M., Sauer, H., Nowotnik, A.C. and Suzdak, P.D. (1997) Neurotrophic immunophilin ligands stimulate structural and functional recovery in neurodegenerative animal models.Proc. Natl. Acad. Sci. USA 94, 2019–2024.

    Article  PubMed  CAS  Google Scholar 

  • Stocker, R., Yamamoto, Y, McDonagh, A.F., Glazer, A.N. and Ames, B.N. (1987) Bilirubin is an antioxidant of possible physiological importance.Science 235, 1043–1046.

    Article  PubMed  CAS  Google Scholar 

  • Svensson, A.L. and Nordberg, A. (1998) Tacrine and donepezil attenuate the neurotoxic effect ofAβ (25–35) in rat PC12 cells.NeuroReport 9, 1519–1522.

    Article  PubMed  CAS  Google Scholar 

  • Syed, F. Ali Martin, J.L., Black, M.D. and Itzhak, Y. (1999) Neuroprotective role of melatonin in methamphetamin- andl-methyl-4-phenyl-l,2,3,6-tetrahydropyridine-induced dopaminergic neurotoxicity.Ann. NY Acad. Sci. 890, 119–120.

    Article  Google Scholar 

  • Tatton, N.A. and Chalmers-Redman, R.M.E. (1998) Mitochondria in neurodegenerative apoptosis: an opportunity to therapy.Ann. Neurol. 44(Suppl. 1), 134–141.

    Article  Google Scholar 

  • Tatton, W.G., Chalmers-Redman, R.M.E., Ju, W.Y.H., Wadia, J. and Tatton, N.A. (1997) Apoptosis in neurodegenerative disorders: potential for therapy by modifying gene transcription.J. Neurol. Transm. (Suppl.) 49, 245–268.

    CAS  Google Scholar 

  • Tatton, N.A., Maclean-Fraser, A., Tatton, W.G., Perl, D.P. and Olanow, W. (1998) A fluorescent double-labeling method to detect and confirm apoptotic nuclei in Parkinson’s disease.Ann. Neurol. 44(Suppl. 1), 142–148.

    Google Scholar 

  • Tipton, K.F. and Singer, T.P. (1993) Advances in our understanding of the mechanisms of the neurotoxicity of MPTP and related compounds.J. Neurochem. 61, 1191–1206.

    Article  PubMed  CAS  Google Scholar 

  • Trotti, D., Rossi, D., Gjesdal, O., Levy, L.M., Racagni, G., Danholt, N.C. and Volterra, A. (1996) Peroxynitrite inhibits glutamate transporter subtypes.J. Biol. Chem. 271, 5976–5979.

    Article  PubMed  CAS  Google Scholar 

  • Vukosavic, S., Dubois-Dauphin, M., Romero, N. and Przedborski, S. (1999) Bax and Bcl-2 interaction in a transgenic mouse model of familial amyotrophic lateral sclerosis.J. Neurochem. 73, 2460–2468.

    Article  PubMed  CAS  Google Scholar 

  • Vymazal, J., Righini, A., Brooks, R.A., Canesi, M., Mariani, C, Leonardi, M. and Pezzoli, G. (1999) Tl and T2 in the brain of healthy subjects, patients with Parkinson disease, and patients with multiple system atrophy: relation to iron content.Radiology 211, 489–495.

    PubMed  CAS  Google Scholar 

  • Wallace, D.C. and Murdoch, D.G. (1999) Mitochondria and dystonia: the movement disorder connection?Proc. Natl. Acad. Sci. USA 96, 1817–1819.

    Article  PubMed  CAS  Google Scholar 

  • Wang, Y, Qin, Z.H., Nakai, M., Chen, R.W., Chuang, D.M. and Chase, T.N. (1999) Co-stimulation of cyclic-AMP-linked metabotropic glutamate receptors in rat striatum attenuates excitotoxin-induced nuclear factor-kappaB activation and apoptosis.Neuroscience 94, 1153–1162.

    Article  PubMed  CAS  Google Scholar 

  • Warzok, R.W., Kessler, C. and Apel, G. (1998)Alzheimer’s Disease and Associated Disorders 12, 33–39.

    Article  CAS  Google Scholar 

  • Wirsching, B.A., Beninger, R.J., Jhamandas, K., Boegman, R.J. and Bialik, M. (1989) Kynurenic acid protects against the neurochemical and behavioural effects of unilateral quinolinic acid injections into the nucleus basalis of rats.Behav. Neurosci. 103, 90–97.

    Article  PubMed  CAS  Google Scholar 

  • Wong, A., Yang, J., Cavadini, P., Gellera, C, Lonnerdal, B., Taroni, F. and Cortopassi, G. (1999) The Friedreich’s ataxia mutation confers cellular sensitivity to oxidant stress which is rescued by chelators of iron and calcium and inhibitors of apoptosis.Hum. Mol. Genet. 8, 425–430.

    Article  PubMed  CAS  Google Scholar 

  • Youdim, M.B.H. (1994) The enigma of neuromelanin in Parkinsonian substantia nigra.J. Neurol. Transm. (Suppl.) 43, 113–122.

    CAS  Google Scholar 

  • Youdim, M.B.H., Grunblatt, E. and Mandel, S. (1999) The pivotal role of iron in NF-κB activation and nigrostriatal dopaminergic neurodegeneration. Prospects for neuroprotection in Parkinson’s disease with iron chelators.Ann. NY Acad. Sci. 890, 7–25.

    Article  PubMed  CAS  Google Scholar 

  • Zamani, R.M., Allen, Y.S., Owen, G.P. and Gray, J.A. (1997) Nicotine modulates the neurotoxic effect of β-amyloid(25- 35) in hippocampal cultures.NeuroReport 8, 513–517.

    Article  PubMed  CAS  Google Scholar 

  • Zhang, J. and Piantadosi, C.A. (1992) Mitochondrial oxidative stress after carbon monoxide hypothermia in the rat brain.J. Clin. Invest. 90, 1193–1199.

    Article  PubMed  CAS  Google Scholar 

  • Zouari, M., Feki, M., Ben Hamida, C, Larnaout, A., Turki, I., Belal, S., Mebazaa, A., Ben Hamida, M. and Hentati, F. (1998) Electrophysiology and nerve biopsy: comparative study in Friedreich’s ataxia and Friedreich’s ataxia phenotype with vitamin E deficiency.Neuromuscul. Disord. 8, 416–425.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurology and Neuroscience, Weill Medical College of Cornell University, 525 East 68th Street, 10021, New York, NY, USA

    M. Flint Beal

  2. Servicio de Psiquiatrk, Hospital 12 de Octobre, Ctra. Andalucia Km. 5,400, 28041, Madrid, Spain

    Tomás Palomo

  3. Department of Pharmacology, Quillen College of Medicine, East Tennessee State University, 37614, Johnson City, TN, USA

    Richard M. Kostrzewa

  4. Department of Psychology, University of Göteborg, Box 500, SE 40530, Sweden, Göteborg

    Trevor Archer

Authors
  1. M. Flint Beal
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Tomás Palomo
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Richard M. Kostrzewa
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Trevor Archer
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Trevor Archer.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Beal, M.F., Palomo, T., Kostrzewa, R.M. et al. Neuroprotective and neurorestorative strategies for neuronal injury. neurotox res 2, 71–84 (2000). https://doi.org/10.1007/BF03033786

Download citation

  • Received:

  • Revised:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03033786

Keywords

Search

Navigation